Latest Insider Transactions at Care Dx, Inc. (CDNA)
This section provides a real-time view of insider transactions for Care Dx, Inc. (CDNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CareDx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CareDx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 04
2021
|
George Bickerstaff |
BUY
Grant, award, or other acquisition
|
Direct |
258
+0.32%
|
-
|
|
Jan 04
2021
|
Christine Cournoyer Director |
BUY
Grant, award, or other acquisition
|
Direct |
237
+1.92%
|
-
|
|
Jan 04
2021
|
Ralph Snyderman Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+0.25%
|
-
|
|
Dec 18
2020
|
Reginald Seeto Director |
SELL
Open market or private sale
|
Direct |
8,363
-2.29%
|
$568,684
$68.92 P/Share
|
|
Dec 14
2020
|
George Bickerstaff |
SELL
Open market or private sale
|
Direct |
10,000
-3.82%
|
$710,000
$71.99 P/Share
|
|
Dec 14
2020
|
Michael Goldberg |
SELL
Open market or private sale
|
Direct |
30,000
-7.91%
|
$2,130,000
$71.12 P/Share
|
|
Dec 07
2020
|
Peter Maag |
SELL
Open market or private sale
|
Direct |
10,000
-0.78%
|
$660,000
$66.39 P/Share
|
|
Dec 07
2020
|
Peter Maag |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.26%
|
$60,000
$6.31 P/Share
|
|
Nov 26
2020
|
Reginald Seeto Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,551
-4.34%
|
$310,856
$56.08 P/Share
|
|
Nov 12
2020
|
William A Hagstrom |
SELL
Open market or private sale
|
Direct |
10,000
-35.0%
|
$540,000
$54.59 P/Share
|
|
Nov 12
2020
|
William A Hagstrom |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.92%
|
$60,000
$6.5 P/Share
|
|
Nov 05
2020
|
Peter Maag |
SELL
Open market or private sale
|
Direct |
10,000
-0.77%
|
$540,000
$54.14 P/Share
|
|
Nov 05
2020
|
Peter Maag |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.15%
|
$60,000
$6.11 P/Share
|
|
Nov 03
2020
|
Michael Brian Bell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
32,574
-23.97%
|
$1,563,552
$48.15 P/Share
|
|
Nov 03
2020
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,640
+3.17%
|
$230,760
$9.24 P/Share
|
|
Nov 02
2020
|
Reginald Seeto Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,100
+4.55%
|
-
|
|
Oct 08
2020
|
Sasha King Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
40,775
-48.42%
|
$2,038,750
$50.62 P/Share
|
|
Oct 08
2020
|
Sasha King Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,779
+4.7%
|
$206,232
$8.07 P/Share
|
|
Oct 05
2020
|
Peter Maag |
SELL
Open market or private sale
|
Direct |
10,000
-2.32%
|
$420,000
$42.11 P/Share
|
|
Oct 05
2020
|
Peter Maag |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.26%
|
$50,000
$5.9 P/Share
|
|
Oct 01
2020
|
Peter Maag |
SELL
Open market or private sale
|
Direct |
20,000
-2.27%
|
$800,000
$40.82 P/Share
|
|
Oct 01
2020
|
Peter Maag |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.24%
|
$100,000
$5.7 P/Share
|
|
Oct 01
2020
|
Christine Cournoyer Director |
BUY
Grant, award, or other acquisition
|
Direct |
407
+3.32%
|
-
|
|
Oct 01
2020
|
Michael Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
1,081
+1.22%
|
-
|
|
Oct 01
2020
|
Ralph Snyderman Director |
BUY
Grant, award, or other acquisition
|
Direct |
370
+0.44%
|
-
|
|
Oct 01
2020
|
George Bickerstaff |
BUY
Grant, award, or other acquisition
|
Direct |
444
+0.49%
|
-
|
|
Sep 30
2020
|
Peter Maag |
SELL
Open market or private sale
|
Direct |
16,992
-3.87%
|
$628,704
$37.59 P/Share
|
|
Sep 30
2020
|
Peter Maag |
BUY
Exercise of conversion of derivative security
|
Direct |
16,992
+3.73%
|
$84,960
$5.49 P/Share
|